Health Canada finds Astrazeneca COVID-19 vaccines from Baltimore plant safe, of high quality
(Reuters) - Canada's health department said on Sunday the 1.5 million doses of the Astrazeneca Plc COVID-19 vaccine imported from Emergent BioSolutions' Baltimore facility were safe and met quality specifications. Read full story
Comments
Post a Comment